CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
Kye Won Park, Sungyang Jo, Seung Hyun Lee, Yun Su Hwang, Dagyo Lee, Ho-Sung Ryu, Sun Ju Chung
JMD. 2020;13(3):205-212.   Published online 2020 September 9    DOI: https://doi.org/10.14802/jmd.20055

Excel Download

Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
Journal of Movement Disorders. 2020;13(3):205-212   Crossref logo
Link1 Link2 Link3

448: Quality of life in early Parkinson’s disease treated with levodopa/carbidopa/entacapone compared to levodopa/carbidopa
Journal of Clinical Neuroscience. 2008;15(3):359   Crossref logo
Link1 Link2

Comparison of 200 mg retarded release levodopa/carbidopa – with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson’s disease
Journal of Neural Transmission. 2007;114(11):1457-1462   Crossref logo
Link1 Link2 Link3

Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study
Movement Disorders. 2016;32(2):283-286   Crossref logo
Link1 Link2

Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off
Journal of Neural Transmission. 2015;122(12):1709-1714   Crossref logo
Link1 Link2 Link3

2.212 Improved adherence to levodopa/carbidopa/entacapone (Stalevo®) or levodopa/carbidopa and entacapone as separate tablets reduces medical care utilization and costs among Parkinson's disease patients
Parkinsonism & Related Disorders. 2007;13:S100-S101   Crossref logo
Link1 Link2

Therapeutic interventions and adjustments in the management of Parkinson disease: role of combined carbidopa/levodopa/entacapone (Stalevo®)
Neuropsychiatric Disease and Treatment. 2010;483   Crossref logo
Link1

Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson’s disease patients with wearing-off: efficacy, safety and feasibility—an open-label, 6-week study
Journal of Neural Transmission. 2009;117(3):333-342   Crossref logo
Link1 Link2 Link3

Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial
Journal of Neural Transmission. 2013;121(4):357-366   Crossref logo
Link1 Link2 Link3

PND37 PATIENT AND PHYSICIAN GLOBAL PERCEPTION OF LEVODOPA/ CARBIDOPA/ENTACAPONE VS. LEVODOPA/CARBIDOPA IN PATIENTS WITH PARKINSON'S DISEASE EXPERIENCING EARLY WEARING-OFF
Value in Health. 2010;13(7):A394-A395   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. JMD has participated in CrossRef Text and Data Mining service since October 29, 2014.